DEVELOPMENT OF BIODEGRADABLE NANOCARRIERS FOR TARGETED DRUG DELIVERY IN OVARIAN CANCER. FMHR. 2025;3(7):500-513. Accessed August 12, 2026. https://fmhr.net/index.php/fmhr/article/view/1116